Researchers working in our R&D centers have years of experience in chemical synthesis and developing new process for valuable APIs and intermediates. We are especially good at these reactions : friedel crafts reaction, Grignard reaction, halogenating reaction, oxidizing reaction, cyclization, acylation, condensation reaction, nitration, sulfonation reaction, catalytic hydrogenation reduction and chemical reductionand have the capacity of equipment: -78C+150C(temp.); 0kg150 kg(pressure).

Our R & D Center is supported with analysis research center that are fully equipped with advanced analytical instruments such as infrared chromatography, gas chromatography, HPLC, metrohm Moisture device and centrifuge. And the R & D Center are also well equipped with synthesis pilot plant, 1-20L rotary steamers, electrothermal constant-temperature dry box, -40-0 low temperature reaction kettle, 1-20L high pressure reaction kettle and 1-20L double-layer glass reaction kettle, etc.
R&D pipeline

Lixin Focuses on mainly four categories: Antineoplastic, cardiovascular, antiplatelet and Nootropic drugs.

R&D Capacity

Lixin is strong in: Polymorphism Study, Asymmetric Synthesis and other reaction types.
Cooperating with: Jiangnan University, China Pharmaceutical University, Suzhou University, etc.
Lixin is also able to provide OEM and contract manufacturing service as per customers' requirements.

  (C)Suzhou Lixin Pharmaceutical Co.,Ltd. About Lixin | Manufacturing | Quality/EHS | R&D | products | Contact